Structure Therapeutics’ aleniglipron Phase 2 shows ~16% placebo-adjusted weight loss; a best-in-class oral GLP-1 with strong cash runway.
Young and the Invested on MSN
These 7 ETFs will fly if 2026's gold rally continues
This article discusses the best gold ETFs available right now.
While bitcoin’s BTC $73,907.94 price rise since the Iran conflict began more than two weeks ago is impressive, the performance of Hyperliquid is even more notable.
MarketBeat on MSN
Winner Winner, Chicken Dinner: El Pollo Loco's Turnaround Recipe
A major move in the restaurant sector captured the market's attention, as El Pollo Loco (NASDAQ: LOCO) shares rose an impressive 17% on March 13. The catalyst for this sudden rally was El Pollo Loco’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results